Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Bioavailability of digoxin and beta-methyl-digoxin.

L Padeletti, F Fantini, P Cinelli

    The Journal of International Medical Research
    |January 1, 1976
    PubMed
    Summary

    This study found no significant differences in how the body absorbs digoxin and beta-methyl-digoxin. Both medications showed comparable bioavailability in healthy volunteers.

    Related Concept Videos

    You might also read

    Related Articles

    Articles linked to this work by shared authors, journal, and citation graph.

    Sort by
    Same author

    SARS-CoV-2 in the sweat of COVID-19-positive patients: a possible route of transmission?

    Journal of the European Academy of Dermatology and Venereology : JEADV·2021
    Same author

    Relapse of chilblain-like lesions during the second wave of coronavirus disease 19.

    Journal of the European Academy of Dermatology and Venereology : JEADV·2021
    Same author

    Response to 'No evidence of SARS-CoV-2 infection by polymerase chain reaction or serology in children with pseudo-chilblain'.

    The British journal of dermatology·2020
    Same author

    Acral cutaneous lesions in the time of COVID-19.

    Journal of the European Academy of Dermatology and Venereology : JEADV·2020
    Same author

    Predictors of Beta-Hexachlorocyclohexane blood levels among people living close to a chemical plant and an illegal dumping site.

    Environmental health : a global access science source·2020
    Same author

    The Hidradenitis suppurativa patient journey in Italy: current status, unmet needs and opportunities.

    Journal of the European Academy of Dermatology and Venereology : JEADV·2016

    Area of Science:

    • Pharmacokinetics
    • Drug bioavailability
    • Clinical pharmacology

    Background:

    • Digoxin is a cardiac glycoside used to treat heart failure and arrhythmias.
    • Beta-methyl-digoxin is a related compound with potential differences in absorption or metabolism.
    • Understanding the comparative bioavailability of different digoxin formulations is crucial for therapeutic equivalence.

    Purpose of the Study:

    • To compare the bioavailability of a single dose of digoxin versus beta-methyl-digoxin.
    • To assess the rate and extent of drug absorption for both formulations.
    • To determine if beta-methyl-digoxin offers equivalent bioavailability to standard digoxin.

    Main Methods:

    • A randomized crossover study design was employed.
    • Four healthy volunteers participated in the study.
    • Drug absorption was evaluated using 6-day cumulative urinary excretion and serial serum concentration measurements.

    Main Results:

    • No statistically significant differences were observed between digoxin and beta-methyl-digoxin.
    • The rate and extent of drug absorption were comparable for both tested products.
    • Urinary excretion and serum concentrations did not reveal disparities in bioavailability.

    Conclusions:

    • Digoxin and beta-methyl-digoxin exhibit similar bioavailability profiles.
    • The findings suggest therapeutic equivalence between the two formulations based on absorption parameters.
    • Further clinical studies may be warranted to confirm these pharmacokinetic findings.

    Related Experiment Videos